These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 37352910)

  • 1. Morning Blood Pressure Surge and Glaucomatous Visual Field Progression in Normal-Tension Glaucoma Patients With Systemic Hypertension.
    Baek MS; Song WK; Kim KE; Lee A; Lee JY; Shin JW; Kook MS
    Am J Ophthalmol; 2023 Oct; 254():161-176. PubMed ID: 37352910
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Baseline Systolic versus Diastolic Blood Pressure Dip and Subsequent Visual Field Progression in Normal-Tension Glaucoma.
    Kwon J; Jo YH; Jeong D; Shon K; Kook MS
    Ophthalmology; 2019 Jul; 126(7):967-979. PubMed ID: 30853468
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characteristics of visual field progression in medically treated normal-tension glaucoma patients with unstable ocular perfusion pressure.
    Sung KR; Cho JW; Lee S; Yun SC; Choi J; Na JH; Lee Y; Kook MS
    Invest Ophthalmol Vis Sci; 2011 Feb; 52(2):737-43. PubMed ID: 20861474
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between daytime variability of blood pressure or ocular perfusion pressure and glaucomatous visual field progression.
    Lee J; Choi J; Jeong D; Kim S; Kook MS
    Am J Ophthalmol; 2015 Sep; 160(3):522-537.e1. PubMed ID: 26052089
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Baseline Central Visual Field Defect as a Risk Factor For NTG Progression: A 5-Year Prospective Study.
    Raman P; Suliman NB; Zahari M; Mohamad NF; Kook MS; Ramli N
    J Glaucoma; 2019 Nov; 28(11):952-957. PubMed ID: 31688446
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical Course and Risk Factors for Visual Field Progression in Normal-Tension Glaucoma With Myopia Without Glaucoma Medications.
    Han JC; Han SH; Park DY; Lee EJ; Kee C
    Am J Ophthalmol; 2020 Jan; 209():77-87. PubMed ID: 31493404
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Twenty-four hour ocular perfusion pressure fluctuation and risk of normal-tension glaucoma progression.
    Sung KR; Lee S; Park SB; Choi J; Kim ST; Yun SC; Kang SY; Cho JW; Kook MS
    Invest Ophthalmol Vis Sci; 2009 Nov; 50(11):5266-74. PubMed ID: 19474398
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low nocturnal diastolic ocular perfusion pressure as a risk factor for NTG progression: a 5-year prospective study.
    Raman P; Suliman NB; Zahari M; Kook M; Ramli N
    Eye (Lond); 2018 Jul; 32(7):1183-1189. PubMed ID: 29491486
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optic Disc Rotation as a Clue for Predicting Visual Field Progression in Myopic Normal-Tension Glaucoma.
    Sung MS; Kang YS; Heo H; Park SW
    Ophthalmology; 2016 Jul; 123(7):1484-93. PubMed ID: 27157844
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Results of long-term monitoring of normal-tension glaucoma patients receiving medical therapy: results of an 18-year follow-up.
    Komori S; Ishida K; Yamamoto T
    Graefes Arch Clin Exp Ophthalmol; 2014 Dec; 252(12):1963-70. PubMed ID: 25128961
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The association between corneal biomechanical parameters and visual field progression in patients with normal tension glaucoma].
    Li BB; Cai Y; Pan YZ; Li M; Fang Y; Tian T; Yan XM
    Zhonghua Yan Ke Za Zhi; 2018 Mar; 54(3):171-176. PubMed ID: 29518874
    [No Abstract]   [Full Text] [Related]  

  • 12. Nocturnal systemic hypotension increases the risk of glaucoma progression.
    Charlson ME; de Moraes CG; Link A; Wells MT; Harmon G; Peterson JC; Ritch R; Liebmann JM
    Ophthalmology; 2014 Oct; 121(10):2004-12. PubMed ID: 24869467
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of Visual Field Progression Rates Among the High Tension Glaucoma, Primary Angle Closure Glaucoma, and Normal Tension Glaucoma.
    Ballae Ganeshrao S; Senthil S; Choudhari N; Sri Durgam S; Garudadri CS
    Invest Ophthalmol Vis Sci; 2019 Mar; 60(4):889-900. PubMed ID: 30835290
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Visual and structural prognosis of the untreated fellow eyes of unilateral normal tension glaucoma patients.
    Cho HK; Suh W; Kee C
    Graefes Arch Clin Exp Ophthalmol; 2015 Sep; 253(9):1547-55. PubMed ID: 26126583
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of intraocular pressure reduction on progression of normal-tension glaucoma with myopic tilted disc and associated risk factors.
    Seol BR; Kim S; Kim DM; Park KH; Jeoung JW; Kim SH
    Jpn J Ophthalmol; 2017 May; 61(3):230-236. PubMed ID: 28280945
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors Associated with Loss of Visual Function in Medically Treated Advanced Normal Tension Glaucoma.
    Kim S; Sung KR
    Curr Eye Res; 2017 Mar; 42(3):429-435. PubMed ID: 27420769
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk factors for disease progression in low-teens normal-tension glaucoma.
    Baek SU; Ha A; Kim DW; Jeoung JW; Park KH; Kim YK
    Br J Ophthalmol; 2020 Jan; 104(1):81-86. PubMed ID: 31055450
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intraocular pressure reduction with topical medications and progression of normal-tension glaucoma: a 12-year mean follow-up study.
    Kim M; Kim DM; Park KH; Kim TW; Jeoung JW; Kim SH
    Acta Ophthalmol; 2013 Jun; 91(4):e270-5. PubMed ID: 23406253
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Study on relationship between control of intraocular pressure and systemic risk factor for visual field progression in normal-tension glaucoma].
    Nakagami T; Yamazaki Y; Hayamizu F
    Nippon Ganka Gakkai Zasshi; 2010 Jul; 114(7):592-7. PubMed ID: 20681254
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of Posterior Sclera on Glaucoma Progression in Treated Myopic Normal-Tension Glaucoma Using Reconstructed Optical Coherence Tomographic Images.
    Kim YC; Koo YH; Jung KI; Park CK
    Invest Ophthalmol Vis Sci; 2019 May; 60(6):2198-2207. PubMed ID: 31108550
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.